Previous studies have reported that de novo missense variants in the CDC42 gene can often result in a number of clinical manifestations, including developmental delay, facial dysmorphism, recurrent infections, and thrombocytopenia [8,9,10,11]. This evidence concerns the gene CDC42 and Thrombocytopenia.